key: cord-0931686-s7py44k4
authors: Ryckman, T. S.; Chin, E. T.; Prince, L.; Leidner, D.; Long, E.; Studdert, D. M.; Salomon, J. A.; Alarid-Escudero, F.; Andrews, J. R.; Goldhaber-Fiebert, J. D.
title: Outbreaks of Covid-19 Variants in Prisons: A Mathematical Modeling Analysis of Vaccination and Re-Opening Policies
date: 2021-05-05
journal: nan
DOI: 10.1101/2021.05.03.21256525
sha: 822f5a1c8a098208ec02cd78e6dd51bbdaf5d59a
doc_id: 931686
cord_uid: s7py44k4

Background: Residents of correctional facilities have experienced disproportionately higher rates of SARS-CoV-2 infection and Covid-19-related mortality. To protect against outbreaks, many prisons and jails imposed heavy restrictions on in-person activities, which are now beginning to lift. Uncertainty surrounds the safety of these moves. Methods and Findings: We obtained system-wide resident-day level data for the California state prison system, the nation's third largest. We used the data to develop a transmission-dynamic stochastic microsimulation model that projects the impact of various policy scenarios on risks of SARS-CoV-2 infections and related hospitalization among residents after an initial infection is introduced to a prison. The policy scenarios vary according to levels of vaccine coverage, baseline immunity, resumption of activities, and use of non-pharmaceutical interventions (e.g., masking, physical distancing). The analyses were conducted across 5 types of prisons that differed in their residential layouts, security levels, and resident demographics. If a viral variant is introduced into a prison that has resumed pre-2020 contact levels, has moderate vaccine coverage, and has no baseline immunity, 23-74% of residents are expected to be infected over 200 days. High vaccination coverage coupled with use of non-pharmaceutical measures reduces cumulative infections to 2-54% of residents. In prisons consisting mostly of dormitory housing, even with high vaccine coverage and non-pharmaceutical interventions, resumption of in-person activities is associated with substantial risk, unless there is high baseline immunity (e.g., [≥]50%) from prior outbreaks. In prisons consisting mostly of cell housing, <10% of residents are expected to become infected, even with no baseline immunity. However, hospitalization risks are substantial in prisons that house medically vulnerable populations, even for prisons consisting mostly of cells. Risks of large outbreaks are substantially higher if there is continued introduction of infections into a prison. Some findings may not be transportable to other carceral settings, and our assumptions regarding viral variants will not be accurate for all variants. Conclusions: Balancing the benefits of resuming normal in-person activities against the risks of Covid-19 outbreaks is a difficult challenge for correctional systems. The policy choices are not strictly binary. To protect against viral variants, prisons should focus on achieving both high vaccine coverage and maintaining widespread use of non-pharmaceutical interventions. With both in place, some prisons, especially those with lower room occupancy that have already had large outbreaks, could safely resume in-person activities, while continuing testing and measures to protect the medically-vulnerable.

In the Covid-19 pandemic's first year, US prison populations had infection and mortality rates 5-6 and 2-3 times higher, respectively, than free-living populations (1) (2) (3) . Overcrowded congregate living spaces, inadequate testing, lack of personal protective equipment and adequate sanitation, mistrust of medical personnel, and policies that disincentivize symptom reporting increase outbreak risks in prisons (3, 4) .

Non-pharmaceutical strategies (e.g. masking and distancing) to reduce transmission are less feasible in such settings, which often house populations that are more medically vulnerable than the general population. Incarcerated individuals living in large dormitories are at especially high risk for infection (5, 6) .

Whether prisons already have sufficient natural immunity from prior outbreaks to safely resume pre-epidemic activities without first achieving high vaccination levels is an open question (7) (8) (9) . Two epidemiological features suggest otherwise.

First, the threshold level of natural immunity required to prevent subsequent outbreaks depends on contacts (10) . This threshold is likely higher in prisons than in the general population given density and crowding. Since 2020, many prisons halted in-person activities, including group therapy, and outside visitation, to reduce contacts and transmission. While resumption of these activities will yield tangible benefits, it also increases contact and transmission risks that could overwhelm the protection conferred by built-up immunity.

Second, SARS-CoV-2 viral variants have emerged that are more transmissible, more likely to result in severe disease, and can evade immunity from prior infection (11) (12) (13) . Genetic sequencing data indicate that more transmissible variants' share of total Covid-19 cases in the US is growing exponentially (14, 15) . The paucity of genetic sequencing in most prisons (3) increases the risk that a new variant will trigger a large outbreak before correctional systems are aware of the introduction, limiting the efficacy of reactive measures like mass testing and quarantine.

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 5, 2021. ; https://doi.org/10.1101/2021.05.03.21256525 doi: medRxiv preprint Whether current vaccination levels in carceral settings are sufficient to halt transmission is thus unclear (16) . As states scale-up vaccination for incarcerated populations (17, 18) , acceptance will determine achievable coverage. Even in states where incarcerated people have been prioritized for vaccination, hesitancy remains a concern (3, 19) . Our study uses simulation modeling to assess how the size and consequences of Covid-19 outbreaks stemming from the introduction of a viral variant into a prison depend on prior immunity, vaccine coverage, and whether and how activities are resumed.

Using a mathematical model, we assess the impact of vaccination on Covid-19 in US prisons. We examine how three factors influence risks of outbreaks and severe outcomes: (1) resumption of in-person activities; (2) use of non-pharmaceutical interventions (NPIs) such as face coverings and physical distancing; and (3) vaccination among incarcerated individuals. We also assess how two exogeneous factors -the introduction of a highly transmissible viral variant and baseline natural immunity from prior outbreaks -affect these estimates. We use detailed data from the California state prison system and facilitate generalizability to other prison systems by simulating a range of prisons that differ in room occupancies, residential layouts, resident demographics, security levels, and contact patterns.

The transmission-dynamic stochastic microsimulation follows individual residents and correctional staff within a prison (Figure 1 , Appendix). We simulate different prisons by instantiating the model with prison-specific characteristics. These include the prison's residential layout: composition of rooms (i.e., cells or dorms) and room occupancy -which has been identified as an especially important risk factor for prison outbreaks (5,6) -and their organization within buildings and yards. They also include the number of residents and their age, sex, comorbidities, security level, room assignment and type, and participation . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 5, 2021. ; https://doi.org/10.1101/2021.05.03.21256525 doi: medRxiv preprint in prison labor or other activities. Correctional staff are characterized by age; the size of the staff population varies by prison. We selected prisons from California's 35 state prisons that demonstrate variation across these characteristics and are comparable to other prison systems in the US. Simulated prisons include: a low to medium security men's prison consisting mostly of dormitories (defined as rooms with ≥ 3 occupants), a low to medium security men's prison with a mix of dorms and cells (rooms with ≤ 2 occupants), a high security men's prison with mostly cells, a women's prison with mixed security levels and mostly cells, and a medical prison that houses older residents and residents with medical vulnerabilities mostly in cells (Appendix).

Daily transmission risk is based on the number of contacts each person has, the proportion of contacts that are infectious, and the probability of transmission by type of infectious contact (equations in Appendix). Residents have contact with their roommates, other residents in the same building, and correctional staff across the prison. Residents who participate in out-of-room activities (labor, school, or other activities) also have contact with other residents in the same yard who participate in those activities.

Transmission risks are highest for in-room contacts, followed by activity contacts, and then building and staff contacts (Table 1 ). Because the model reflects differences in residents' housing and activity participation, it captures variation in individuals' exposures and thus replicates prior study findings (5) (Appendix). Correctional staff are assumed to mix homogenously with each other and with residents.

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 5, 2021. ; https://doi.org/10.1101/2021.05.03.21256525 doi: medRxiv preprint Based on Verity et al. (23) Relative risk of hospitalization (severe infection) conditional on symptomatic infection with variant of concern (relative to wild type)

Tuite et al. (24) Relative risk of death conditional on severe infection with variant of concern (relative to wild type)

Tuite et al. (24) . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) Resident and correctional worker baseline immunity to wild-type infection 0%, 25%, 50% Assumed, varies by scenario . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 5, 2021. ; https://doi.org/10.1101/2021.05.03.21256525 doi: medRxiv preprint

Those with symptomatic infection have age-and comorbidity-specific risks of severe Covid-19 requiring hospitalization and of Covid-19-related mortality. Individuals who survive recover and are immune to infection. Individuals also face background age-and sex-specific mortality risks (Appendix). Covid-19 natural history is the same for incarcerated individuals and correctional staff.

Reflecting California prison policies, in our model infected individuals can be detected via symptom screening, surveillance testing, or reactive testing, triggered by other cases detected nearby 

We model re-opening as a return to pre-Covid out-of-room activity levels and doubling of building and staff contacts, the latter based on average differences between pre-Covid and Covid activity levels. We assess re-opening with or without NPIs (e.g., facial coverings and physical distancing during in-person activities) that reduce transmission risks from contacts resulting from re-opening by 75%. These NPIs are assumed to already be in place in scenarios that keep activities at current levels.

We consider scenarios in which either a new, more transmissible and severe SARS-CoV-2 variant like B.1.1.7 (12, 13, 24) or non-variant (wild type) SARS-CoV-2 infection is introduced into a prison.

Scenarios are also differentiated by the size of prior outbreaks and consequent baseline immunity levels in . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 5, 2021. ; 1 0 the incarcerated and staff populations. Immunity is modeled as moderately less protective against the new variant than the wild type (Table 1) .

We analyze two levels of vaccine acceptance among residents (90% "idealized" acceptance, lower and age-varying "realistic" acceptance; Table 1 ). Based on early evidence from California prisons, we assume that 40% of staff are vaccinated and that resident and staff vaccination is achieved before an infection is imported into the prison.

Vaccine efficacy was based on Pfizer-BioNTech and Moderna trials and observational studies that indicate lower efficacy against transmissibility than against clinical infection and higher efficacy after complete vaccination, compared with efficacy after the first dose (Table 1 ) (25, 26) . We assumed the vaccine is moderately less effective against new variants than wild type Covid-19 (Table 1) .

The California Department of Corrections and Rehabilitation (CDCR) provided daily individual-level data on all residents in its custody. Data describe sociodemographic characteristics, housing status, chronic conditions and health status, participation in labor and other activities, and Covid-19 testing, infection, and vaccination status. We supplemented these data with literature-based estimates related to Covid-19 epidemiology, testing, and vaccination and public data describing correctional staff (Table 1) .

We compared total resident infections (regardless of detection and symptoms) and severe cases (requiring hospitalization and possibly resulting in death) across scenarios and policies. We computed cumulative risks of these outcomes over 200 days.

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) 1 1

The model is constructed in R (version 3.6.3). We initiated simulations by seeding one infected resident in a prison and compared mean outcomes from 500 simulations across each scenario and prison, employing variance reduction techniques (31) .

Stanford University's Institutional Review Board approved the protocol (IRB-55835).

Risks of Covid-19 outbreaks are highest when a viral variant is introduced to a prison with low baseline immunity where only moderate but realistic vaccination coverage has been achieved and activities have been reopened absent NPIs (Figure 2, panel A) . In these settings, the percentage of residents infected over Achieving 90% vaccination coverage of residents substantially reduces expected outbreak sizes ( Figure 2, panel B) . The largest reductions from high vaccine coverage relative to realistic coverage are in settings that already have high baseline immunity and/or do not resume in-person activities. In these settings, high vaccination coverage yields an approximately two-fold reduction in infections. In settings with lower immunity that re-open, achieving high vaccine coverage is still beneficial but has less impact.

Additionally, NPIs that are 75% effective are most impactful in settings where vaccination coverage and baseline immunity are already high. Thus, NPIs and vaccination are complementary interventions, not substitutes.

Severe outcomes follow similar patterns to infections, with several notable exceptions ( Figure 3 ). The highest hospitalization levels are expected when a new variant is introduced to a prison with dorms and low baseline immunity that has resumed activities without NPI use (Figure 3 panel A) . In these settings, with realistic vaccine acceptance, between 12 and 17 hospitalizations per 1000 residents are expected.

Achieving high vaccination coverage effectively halves these hospitalizations (6-10 per 1000; Figure 3 panel B). High vaccination coverage reduces hospitalization to an even greater degree when these prisons with dorms do not resume activities (9-10 per 1000 with realistic vaccine acceptance vs. 3 per 1000 with idealized vaccine acceptance). Because vaccines yield greater protection against symptomatic infections than transmissibility, they have a larger impact on incidence of severe outcomes than on infections.

In each scenario, medical prisons are expected to have the lowest levels of cumulative infections among the five prison types. In addition to having more protections in place than other prison types, residents of the medical prison we modeled mostly live in cells within many small buildings, reducing opportunities for rapid spread across the prison. However, residents of medical prisons also tend to be older and have more comorbidities, increasing their risk of severe outcomes from infection. Those vulnerabilities manifest in disproportionately high rates of hospitalization (Appendix Figure S13 ). While fewer infections are expected in medical prisons, hospitalizations are in some scenarios double those in . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 5, 2021. ; https://doi.org/10.1101/2021.05.03.21256525 doi: medRxiv preprint the high security prison with mostly cells. With re-opening absent NPI use, low baseline immunity, and realistic vaccination levels, hospitalizations in medical prisons could be as high as 23 per 1000 residents, translating to almost 20 Covid-related deaths in a prison of 3000 people (Appendix Figure S14 ).

Women's prisons are similar to medical prisons in this respect. Since California has no women's medical prison, medically vulnerable women are housed in one of two general population women's prisons. While the women's prison we model has mostly cells and similar infection levels as the high security men's prison with mostly cells, it experiences higher rates of hospitalizations.

Vaccination reduces the proportion of infections that require hospitalization and hence, compared to no vaccination, conveys additional benefits to older and medically vulnerable residents, both because they are at greater risk of adverse outcomes and because they have observably higher levels of vaccine acceptance (Appendix Figures S13, S15-S16).

Cumulative infections and severe cases are expected to be substantially lower if a wild type infection is introduced to a prison, compared to a new variant introduction (Appendix Figures S17-S18) .

With more realistic vaccine coverage, prisons with low baseline immunity, especially those with dorms, are still at risk of large outbreaks (19-23% of residents infected) if activities are resumed without NPIs in place. With high vaccine coverage, even settings with low baseline immunity and high levels of contacts are anticipated to have few infections (1% of residents infected or less). However, as variants predominate globally, the likelihood that infection introductions will be new variants like B.1.1.7 grows as well.

Many prisons have experienced repeated importations of infection, in which case outbreaks are far less likely to die out. In an analysis that allowed for repeated importation, which could arise from staff, new arrivals, or transfers, increases in resident infections from resumption of in-person activities are substantially larger than in our main results (Figure 4, Appendix Figure S19 ). The biggest differences . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 5, 2021.

occur in settings that are at lower risk in the main analysis: those with high baseline immunity and NPIs in place and celled, women's, and medical prisons. With realistic vaccine coverage, resumption of activities in these three prison types is expected to result in 5-27% of residents infected if there is high baseline immunity and 27-68% of residents infected if there is no baseline immunity, translating to substantial expected numbers of hospitalizations (i.e., 21 per 1000 residents in medical prisons; Appendix Figure S20 ).

Our main analyses assumed that vaccination of both residents and correctional staff occurred prior to the introduction of a new infection. In many states, however, vaccination of incarcerated populations is at an early stage as of the writing of this paper, with a minority of residents vaccinated.

Vaccination of residents has substantially less impact when scaled up concurrently with infection introduction, and outbreaks in these settings are expected to be far worse. In settings that are currently at lower risk, such as prisons with cells, moderate to high baseline immunity, and 90% vaccine coverage, outbreaks are twice as large with concurrent vaccination scale-up compared to completed vaccination scale-up at baseline (Appendix Figures S21-S22) .

Given limited available data on correctional staff and flatlining of staff coverage in California prisons, we did not focus on analyzing the effects of increasing staff coverage. However, even if staff coverage doubled to 80%, once an infection is already introduced to a prison, this higher coverage was a relatively minor determinant of resident infections and hospitalizations (Appendix Figures S23-S24 ).

As highly transmissible Covid-19 viral variants proliferate throughout the US, their introduction into the nation's 110 federal prisons and 1,833 state prisons is inevitable (32) . Resumption of in-person activities, while undoubtedly important for the health and welfare of incarcerated people, can also greatly increase the risk and size of outbreaks. Achieving high levels of vaccination prior to resumption of in-person . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 5, 2021. ; https://doi.org/10.1101/2021.05.03.21256525 doi: medRxiv preprint activities lowers risks, as does continuing widespread use of effective NPIs. These findings hold even in prisons that predominantly house residents in lower-occupancy rooms, or that have accrued substantial levels of natural immunity from prior outbreaks.

Resuming in-person activities safely requires a multi-faceted approach. In addition to vaccination and NPIs (e.g., masking) to reduce transmission, other measures may prevent the introduction of infections, limit the extent of spread, or mitigate harms. Sensitivity analyses showed a substantial increase in expected infections and hospitalizations when the likelihood of repeated importation of infections is high (Figure 4) , emphasizing the importance of preventing infections from being introduced. While of limited utility for controlling outbreaks once an infection is introduced (Appendix Figure S23 ), staff vaccination is crucial for choking one of the main avenues of introduction (6, 33) . Maintaining ongoing screening and testing of residents, staff, and visitors may also prevent introductions and limit the spread of prison outbreaks. Furthermore, analysis of hospitalizations ( Figure 3 ) reveals that older and medically vulnerable residents should receive additional protections beyond vaccine priority, such as lower occupancy housing and additional NPIs. Our study demonstrates the benefits of lower occupancy housing and points to the potential impact of depopulation (16) , which other analyses have concluded is an important strategy to reduce transmission (34, 35) .

The frequency of importation of infections is likely setting-specific given differences in ongoing community epidemics and vaccination coverage. Whether outbreaks more closely resemble our main analysis with a single imported infection (Figure 2 ) or our sensitivity analysis with repeated importation ( Figure 4 ) depends on setting, future trends in infections, and measures to reduce introductions. Where

Covid-19 infection rates in the general population are high or in carceral settings that have large inflows, such as reception centers and jails, repeated importation of infections is more likely, and our main projections ( Figure 2 ) would be underestimates.

Our main results reveal that prioritizing immediate efforts to achieve widespread vaccination among incarcerated people is critical (Figure 2 ). Our sensitivity analysis shows that if vaccination scale-. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 5, 2021. ; https://doi.org/10.1101/2021.05.03.21256525 doi: medRxiv preprint up is delayed and an infection is introduced in the meantime, the rate of spread is likely to outpace feasible vaccine scale-up, especially in prisons that have resumed in-person activities (Appendix Figure   S21 ). Currently, vaccine coverage and acceptance among incarcerated people and correctional staff is highly variable across prison systems (17) (18) (19) . Employing the best-available vaccination offer and reoffer strategies may be required to increase acceptance especially among those who perceive their risk to be low or are distrustful of prison authorities or healthcare providers (19, 36) .

Regular surveillance testing arms prison health officials with early knowledge of the presence and spread of infections but, to our knowledge, most correctional systems are not using genetic sequencing technology to surveil for the presence of variants. Hence, detection of an outbreak cannot indicate whether the additional precautions needed to curb the spread of a variant of concern are necessary.

Alternatively, the seeding of wild type virus may not warrant complete shutdown (Appendix Figure S17 -S18). Until prisons can rapidly distinguish between wild type infections and variants of concern, detecting new infections may trigger policies that under-or over-protect residents and staff.

Our study has several limitations, First, our results may not be fully generalizable to other carceral settings. The impacts of infection introduction on incarcerated populations depend in part on how likely prisons are to detect outbreaks and take measures to isolate and quarantine. Our results are based on modeling of widespread testing as practiced in California's prisons during 2020-21. However, in settings where screening and testing are less intensive, the risk and size of outbreaks are likely to be larger than our estimates. Although we modeled a range of prison types, incarcerated populations, and levels of prior immunity, outcomes in individual prisons could differ if their housing configurations or demographics diverge substantially from those modeled. Second, while we considered variant scenarios that broadly represent variants like B.1.1.7 along with scenarios considering introduction of wild type variants, other variants are currently circulating globally, and new variants are emerging even as the scientific community works to keep pace in characterizing them epidemiologically (12, 15) . Some variants may be able to completely evade natural immunity from prior wild type infection; although we did not model . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted May 5, 2021. ; https://doi.org/10.1101/2021.05.03.21256525 doi: medRxiv preprint these explicitly, we did model equivalent scenarios with 0% baseline immunity. However, variants that are simultaneously able to avoid vaccine-induced immunity and much more likely to cause severe outcomes, though not yet detected, would require further evaluation.

Ultimately, prison health authorities will need to determine to what extent the risks of infection and serious Covid-19 outcomes must be reduced before the benefits of resumption of in-person activities outweigh the risks. While vaccination reduces risks of serious Covid-19 outcomes, the longer-term implications of even mild infections themselves are not yet well understood. Published studies have detailed long-term sequelae from both mild and severe Covid-19 infections, including respiratory conditions, cardiovascular disease, and mental health disorders (37, 38) . Furthermore, outbreaks in prisons can have consequences for the broader community and uncontrolled spread of the virus can lead to further mutations that produce even harder to combat variants, as has been observed for other infectious diseases (39, 40) . Decision-making regarding pandemic control should be integrated between public health authorities in both incarcerated and free-living settings. Neglecting prison health and deprioritizing vaccination is both unethical and bad policy.

Our analysis yields important policy conclusions based on models that incorporate detailed primary data from the second-largest state prison system in the United States, explicitly reflect demography, residential structure, and mixing over a range of prison types, and can reproduce the size and heterogeneity of viral spread reported in the literature. In summary, to enable resumption of in-person activities so important for the health and wellbeing of incarcerated people, prisons should prioritize widespread vaccination of their populations as soon as possible, remain dedicated to NPIs and regular surveillance testing including genetic sequencing, and continue to protect vulnerable populations.

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. . CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The left panel shows possible state transitions and outcomes for an individual who becomes infected. The right panel shows the distributions and transmission of individuals within a prison. Thick black boxes on the right denote buildings within prison yards, while thin black boxes denote rooms within buildings, and arrows designate different possible routes of transmission from infectious individuals: within-room, within-building, within-yard, staff-to-staff, staff-to-resident, and resident-to-staff. Figure S19 ).

. CC-BY-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted May 5, 2021. ; https://doi.org/10.1101/2021.05.03.21256525 doi: medRxiv preprint

COVID-19 Cases and Deaths in Federal and State Prisons

COVID-19 Case and Mortality Rates in the Federal Bureau of Prisons

Incarcerated and Infected: How the Virus Tore Through the U.S. Prison System. The New York Times

Committee on the Best Practices for Implementing Decarceration as a Strategy to Mitigate the Spread of COVID-19 in Correctional Facilities. Decarcerating Correctional Facilities during COVID-19: Advancing Health, Equity, and Safety

The National Academies Press

Covid-19 in the California State Prison System: An Observational Study of Decarceration, Ongoing Risks, and Risk Factors. medRxiv

Mass Testing for SARS-CoV-2 in 16 Prisons and Jails -Six Jurisdictions

After rampant COVID cases and mass vaccines, is California's prison system nearing 'herd immunity'?

California prisons had so many COVID cases, they now have herd immunity. More could follow. The Sacramento Bee

The false promise of herd immunity for COVID-19

Modeling Infectious Diseases in Humans and Animals

SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants

SARS-CoV-2 Variant Classifications and Definitions

Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological study. The Lancet Public Health

More Contagious Variant Is Spreading Fast in U.S., Even as Overall Cases Level Off. The New York Times

info: a standardized, open-source database of COVID-19 resources and epidemiology data

Vaccination plus Decarceration -Stopping Covid-19 in Jails and Prisons

Incarcerated people and corrections staff should be prioritized in COVID-19 vaccination plans

UCLA Law COVID-19 Behind Bars Data Project

Covid-19 Vaccine Acceptance among Residents of California State Prisons. Forthcoming

Temporal dynamics in viral shedding and transmissibility of COVID-19

The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application

COVID-19 infectivity profile correction

Estimates of the severity of coronavirus disease 2019: a model-based analysis. The Lancet Infectious Diseases

COVID-19 Hospitalizations, ICU Admissions and Deaths Associated with the New Variants of Concern

Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients. The Lancet

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction-Based SARS-CoV-2 Tests by Time Since Exposure

Census of State and Federal Correctional Facilities

The United States Census Bureau

Keeping the Noise Down: Common Random Numbers for Disease Simulation Modeling. Health Care Manag Sci

Mass Incarceration: The Whole Pie

Rapid Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in Detention Facility

Effectiveness of interventions to reduce COVID-19 transmission in a large urban jail: a model-based analysis

Prison Population Reductions and COVID-19: A Latent Profile Analysis Synthesizing Recent Evidence From the Texas State Prison System

Willingness to Receive a COVID-19 Vaccination Among Incarcerated or Detained Persons in Correctional and Detention Facilities -Four States

High-dimensional characterization of post-acute sequalae of COVID-19

Evaluating strategies for control of tuberculosis in prisons and prevention of spillover into communities: An observational and modeling study from Brazil

We thank staff members at the California Department of Corrections and Rehabilitation for providing data and assistance with interpretation of study results. We would also like to thank Liesl Hagan, MPH at